Navigation Links
ECG Reading May Predict Death, Rehospitalization Risk
Date:6/10/2008

Measurement is inexpensive, simple to perform, yields instant result, study says

TUESDAY, June 10 (HealthDay News) -- Hospitalized heart failure patients who have a longer than normal QRS duration (a measurement of the electrical conducting time of the heart on an electrocardiogram) appear to have a high risk of death or rehospitalization, U.S. researchers report.

They analyzed data from 2,962 patients hospitalized for heart failure who had a left ventricular ejection fraction (LVEF -- a measure of how well the left ventricle of the heart pumps with each contraction) of 40 percent or less. Of those patients, 1,641 had a normal QRS duration (less than 120 ms) and 1,321 had a prolonged QRS duration (120 ms or greater).

During follow-up of 9.9 months, 678 of the patients died, including 1,641 patients (18.7 percent) with normal QRS duration and 371 patients (28.1 percent) with prolonged QRS duration. Rates of cardiovascular death or rehospitalization for heart failure were 32.4 percent for patients with normal QRS and 41.6 percent for those with prolonged QRS duration.

After they adjusted for a number of variables, the researchers concluded that patients with prolonged QRS duration were 24 percent more likely to die and 28 percent more likely to suffer cardiovascular-related death or rehospitalization for heart failure than those with normal QRS duration.

The study appears in the June 11 issue of the Journal of the American Medical Association.

"In this analysis, a prolonged QRS duration was present in 45 percent of patients admitted with heart failure, and reduced LVEF, did not appear to significantly change during hospitalization, and was independently associated with high post-discharge mortality and readmission rate. This high morbidity and mortality was observed even though patients were well-treated with standard medical therapy that included beta-blockers and angiotensin-converting enzyme [ACE] inhibitors or angiotensin II receptor blockers [ARBs]," wrote the researchers from the Northwestern University Feinberg School of Medicine in Chicago.

"Measurement of the QRS duration on an ECG has significant advantages as a tool in the clinical setting. It is relatively inexpensive, simple to perform, and yields an instant result. The measurement is objective and does not require specialized training to interpret. In addition, the QRS duration is stable in the majority of patients during the course of their hospitalization. Perhaps most important, a prolonged QRS duration becomes a potential target for intervention [with existing therapy], which may improve post-discharge mortality and morbidity," the researchers wrote.

More information

The American Heart Association has more about heart failure.



-- Robert Preidt



SOURCE: Journal of the American Medical Association, news release, June 10, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. HCV and HBV spreading more slowly among injection drug users in San Francisco
2. ClassMate Reader - Portable reading system supports K-12 students with reading difficulties
3. Sound training rewires dyslexic childrens brains for reading
4. Diagnostic Mammogram Readings Vary by Radiologist
5. VA Salutes Volunteers Spreading Holiday Cheer
6. Optimal Readings Appoints Operations Veteran Rita Edwards as SVP Clinical Operations
7. Optimal Readings Selected to Present at CEDs 25th Annual Venture Conference
8. New CDC Study Shows Smoke-Free Laws Spreading Across U.S. and Should Spur Remaining States to Take Action
9. Who Knew You Could Learn to Lose Weight by Reading an Enjoyable Novel?
10. Formula Puts Doctor, Patient Glucose Readings on Same Page
11. Waist-to-hip ratio may better predict cardiovascular risk than body mass index
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... A quote from Dr. Edward ... comments on social media that offer a rare glimpse into the mind of those ... and New York Times bestselling author, has described people with ADHD as having “Ferrari ...
(Date:12/7/2016)... Hollywood, Fl (PRWEB) , ... December 07, 2016 , ... When it came time to ... new heart. Just 40 minutes later, the Pediatric Heart Transplant team at Joe ... true making the Weston teen the hospital’s 30th heart transplant recipient. , “He was ...
(Date:12/7/2016)... ... 07, 2016 , ... Baciocco Brothers Insurance Agency, a northern ... Sacramento/Folsom region, is initiating a charity event to raise support and awareness for ... treatment center in Sacramento works to provide area teens and families with treatment ...
(Date:12/7/2016)... ... December 07, 2016 , ... AlignLife clinics nationwide are giving ... are not fortunate enough to receive bountiful gifts wrapped tightly under a Christmas Tree. ... to the children of the world. , In exchange for generous donations, customers will ...
(Date:12/7/2016)... ... 2016 , ... Sharon Kleyne, host of the nationally syndicated radio program, The ... of America, declared on her radio program in November 2016 the need to educate ... bullies attack leaders in corporate America, they are trying to take advantage of successful ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)...  The Corporate Whistleblower Center is urging ... anytime at 866-714-6466 if they possess proof a pharmaceutical company ... Aside from the innocent patients frequently being the victims, these types ... practices target Medicare recipients or the elderly. ... ...
(Date:12/7/2016)... Conn. , Dec. 7, 2016 According to ... in more than one-third (38%) of patients with non-small cell ... epidermal growth factor receptor (EGFR) genetic mutation status. The findings ... ( LBA ID #6067 #P3.02b ) at the ... Vienna, Austria . The survey results revealed ...
(Date:12/7/2016)... Conn. , Dec. 7, 2016 ... II trial in patients with unresectable malignant pleural ... survival (PFS). The data, presented at the 17 ... in Vienna , showed nintedanib ... to placebo plus pemetrexed/cisplatin, with a significantly improved ...
Breaking Medicine Technology: